{"id":"W4249072217","doi":"10.1200/jco.2012.30.27_suppl.125","title":"BOLERO-2: Health-related quality-of-life (HRQoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cambridge Memorial Hospital","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Hazard ratio; Aromatase inhibitor; Everolimus; Placebo; Oncology; Clinical endpoint; Quality of life (healthcare); Proportional hazards model; Interim analysis; Cancer; Randomized controlled trial; Confidence interval; Aromatase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003437696,0.0008993796,0.001875626,0.0004827798,0.0002095969,0.0009314283,0.0007887269,0.0006591757,0.006801718],"category_scores_gemma":[0.002033985,0.0003852898,0.002541182,0.0003699037,0.0005485903,0.0005776872,0.0006910639,0.001786798,0.0004942394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001088985,"about_ca_system_score_gemma":0.0008787505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007626133,"about_ca_topic_score_gemma":0.002583207,"domain_scores_codex":[0.9989503,0.0006871903,0.00005822286,0.0001144204,0.00009054953,0.00009938502],"domain_scores_gemma":[0.999193,0.0002239323,0.000324192,0.00003731724,0.00003147604,0.0001900273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9487504,0.005803016,0.004360719,0.001410446,0.002629336,0.00002057817,0.00005846546,0.001188808,0.002706674,0.0001213637,0.001171779,0.03177842],"study_design_scores_gemma":[0.7650265,0.1840723,0.04117782,0.0003154165,0.002975459,0.0001196389,0.00004929227,0.001786857,0.001358757,0.0002202771,0.002850144,0.0000475293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720309,0.01903649,0.0004666593,0.0006353915,0.0002161508,0.001849039,0.002377927,0.00007620089,0.003311289],"genre_scores_gemma":[0.9845089,0.004119375,0.001971354,0.0007413994,0.000178398,0.002901216,0.002740317,0.000018963,0.002820066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006801718,"threshold_uncertainty_score":0.02275401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2168430512842483,"score_gpt":0.5177775195784704,"score_spread":0.3009344682942221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}